Plain-English translation of NCT03183115 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing radiofrequency ablation (RFA)—a procedure that uses controlled heat to treat tissue in your esophagus—to prevent cancer from returning after you've had early-stage esophageal cancer removed. You've already had a procedure called endoscopic submucosal dissection (ESD) to remove your cancer. This new treatment aims to reduce the chance that new cancerous spots will develop in the lining of your esophagus over time.
After early esophageal cancer is removed, about half of patients develop new cancerous spots within 5 years. Patients with a particular pattern of pre-cancerous cells in the esophageal lining (called 'speckled' tissue) are at especially high risk. Right now, doctors mainly watch these patients closely with repeated scans, but there's no proven way to stop cancer from coming back—so this trial is testing whether treating the high-risk tissue with heat might prevent that.
You likely qualify if…
You likely don't qualify if…
If you join the treatment group, you will have the radiofrequency ablation procedure about 3 months after your cancer removal surgery. After the procedure, you'll take an oral steroid medication for 4 weeks to help prevent scarring. You'll then be followed up with regular surveillance endoscopies to watch for any signs of cancer returning. The control group will receive surveillance endoscopies alone without the heat treatment, so researchers can compare how well the treatment works.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Taiwan